1. Hoffman JIE, Kaplan S. The incidence of congenital heart disease. J Am Coll Cardiol. 2002;39:1890-900.
2. Kouchoukos N.T., Blackstone E.H., Hanley F.L., Kirklin J.K. Kirklin/Barratt-Boyes cardiac surgery: morphology, diagnostic criteria, natural history, techniques, results, and indications. - 4th ed. Philadelphia: Elsevier; 2013.
3. Du Z.D., Hijazi Z.M., Kleinman C.S., Silverman N.H., Larntz K. Comparison between transcatheter and surgical closure of secundum atrial septal defect in children and adults: results of a multicenter nonrandomized trial. J. Am. Coll. Cardiol. 2002; 39: 1836-44.
4. Loscalzo J. Paradoxical embolism: clinical presentation, diagnostic strategies, and therapeutic options. Am Heart J. 1986; 112: 141-5.
5. Ward R, Jones D, Haponik EF. Paradoxical embolism. An underrecognized problem. Chest. 1995;108: 549 -58.
6. Waltz DA, Boucek MM, Edwards LB, et al. Registry of the International Society for Heart and Lung Transplantation: ninth official pediatric lung and heart-lung transplantation report-2006. J Heart Lung Transplant. 2006; 25: 904 -11.
7. Choong CK, Meyers BF, Battafarano RJ, et al. Lung cancer resection combined with lung volume reduction in patients with severe emphysema. J Thorac Cardiovasc Surg. 2004; 127: 1323-31.
8. Fuster V, Brandenburg RO, McGoon DC, Giuliani ER. Clinical approach and management of congenital heart disease in the adolescent and adult. Cardiovasc Clin. 1980; 10: 161-97.
9. Rigby M. Atrial septal defect. In: Diagnosis and Management of Adult Congenital Heart Disease. London: Churchill Livingston, 2003.
10. Ballester M, Presbitero P, Foale R, Rickards A, McDonald L. Prolapse of the mitral valve in secundum atrial septal defect: a functional mechanism. Eur Heart J. 1983; 4: 472- 6.
11. Silka MJ, Rice MJ. Paradoxic embolism due to altered hemodynamic sequencing following transvenous pacing. Pacing Clin Electrophysiol. 1991; 14: 499 -503.
12. Ward R, Jones D, Haponik EF. Paradoxical embolism. An underrecognized problem. Chest. 1995; 108: 549 -58.
13. Konstantinides S, Geibel A, Olschewski M, et al. A comparison of surgical and medical therapy for atrial septal defect in adults. N Engl J Med. 1995; 333: 469 -73.
14. Craig RJ, Selzer A. Natural history and prognosis of atrial septal defect. Circulation. 1968; 37: 805-15.
15. Fraker TD Jr, Harris PJ, Behar VS, Kisslo JA. Detection and exclusion of interatrial shunts by two-dimensional echocardiography and peripheral venous injection. Circulation. 1979; 59: 379-84.
16. Freed MD, Nadas AS, Norwood WI, Castaneda AR. Is routine preoperative cardiac catheterization necessary before repair of secundum and sinus venosus atrial septal defects? J Am Coll Cardiol. 1984; 4: 333- 6.
17. Shub C, Tajik AJ, Seward JB, Hagler DJ, Danielson GK. Surgical repair of uncomplicated atrial septal defect without “routine” preoperative cardiac catheterization. J Am Coll Cardiol. 1985; 6: 49 -54.
18. Kronzon I, Tunick PA, Freedberg RS, Trehan N, Rosenzweig BP, Schwinger ME. Transesophageal echocardiography is superior to transthoracic echocardiography in the diagnosis of sinus venosus atrial septal defect. J Am Coll Cardiol. 1991; 17: 537- 42.
19. Prystowsky EN, Benson DW Jr, Fuster V, et al. Management of patients with atrial fibrillation. A statement for healthcare professionals. From the Subcommittee on Electrocardiography and Electrophysiology, American Heart Association. Circulation. 1996; 93: 1262-77.
20. Fischer G, Stieh J, Uebing A, Hoffmann U, Morf G, Kramer HH. Experience with transcatheter closure of secundum atrial septal defects using the Amplatzer septal occluder: a single centre study in 236 consecutive patients. Heart. 2003; 89: 199 -204.
21. Dhillon R, Thanopoulos B, Tsaousis G, Triposkiadis F, Kyriakidis M, Redington A. Transcatheter closure of atrial septal defects in adults with the Amplatzer septal occluder. Heart. 1999; 82: 559-62.
22. Morris CD, Reller MD, Menashe VD. Thirty-year incidence of infective endocarditis after surgery for congenital heart defect. JAMA. 1998; 279: 599-603.
23. Cooper WO, Hernandez-Diaz S, Arbogast PG, et al. Major congenital malformations after first-trimester exposure to ACE inhibitors. N Engl J Med. 2006; 354: 2443-51.
24. Schaefer C, Hannemann D, Meister R, et al. Vitamin K antagonists and pregnancy outcome. A multi-centre prospective study. Thromb Haemost. 2006; 95: 949 -57.
25. Famuyide AO, Hopkins MR, El-Nashar SA, et al. Hysteroscopic sterilization in women with severe cardiac disease: experience at a tertiary center. Mayo Clin Proc. 2008; 83: 431- 8.
26. Epstein AE, Di Marco JP, Ellenbogen KA, et al. ACC/AHA/HRS 2008 guidelines for device-based therapy of cardiac rhythm abnomalities: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to revise the ACC/AHA/NASPE 2002 guideline update for implantation of cardiac pacemakers and antiarrhythmia devices). J Am Coll Cardiol. 2008; 51: e1- 62.
27. Khositseth A, Danielson GK, Dearani JA, Munger TM, Porter CJ. upraventricular tachyarrhythmias in Ebstein anomaly: management and outcome. J Thorac Cardiovasc Surg. 2004; 128: 826 -33.
28. Chetaille P, Walsh EP, Triedman JK. Outcomes of radiofrequency catheter ablation of atrioventricular reciprocating tachycardia in patients with congenital heart disease. Heart Rhythm. 2004; 1: 168 -73.
29 Nakagawa H, Shah N, Matsudaira K, et al Characterization of reentrant circuit in macroreentrant right atrial tachycardia after surgical repair of congenital heart disease: isolated channels between scars allow “focal” ablation. Circulation . 2001; 103: 699 -709.
30. Anand N, McCrindle BW, Chiu CC, et al. Chronotropic incompetence in young patients with late postoperative atrial flutter: a case-control study. Eur Heart J. 2006; 27: 2069 -73.